COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
LIR Life Sciences Launches Ex Vivo Animal Study to Evaluate Protamine Enhanced Transdermal Transport of Larger Format Therapeutic Molecules
LIR Life Sciences Corp. announces the launch of a controlled ex vivo porcine skin study to evaluate protamine's impact on transdermal movement of macromolecular therapeutics. The study aims to advance needle-free delivery options for larger molecules -
COMMUNIQUÉ DE PRESSE
Onco-Innovations Announces Successful Scale-Up of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for its PNKP Inhibitor Technology Program
Onco-Innovations successfully scales up key intermediates A83 and B4, advancing its CMC program for nanoparticle-based PNKP inhibitor drug ONC010. Collaborates with Dalton Pharma Services for process optimization and future GMP manufacturing -
-
-
-
-
COMMUNIQUÉ DE PRESSE
German Federal Ministry for Economic Affairs and Energy Officially Opens HyProMag Second Plant in Pforzheim, Germany
German Federal Ministry of Economic Affairs and Energy opens HyProMag plant in Pforzheim, Germany. HyProMag USA accelerates magnet product verification opportunities. CoTec Holdings Corp. comments on the milestone -
-
